Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial-Reference-Cited by-同舟云学术

Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Published:2007-06 Issue:12 Volume:99 Page:S34-S43
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Gerstein Hertzel C.,Riddle Matthew C.,Kendall David M.,Cohen Robert M.,Goland Robin,Feinglos Mark N.,Kirk Julienne K.,Hamilton Bruce P.,Ismail-Beigi Faramarz,Feeney Patricia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial;Stamler;Diabetes Care,1993

2. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk;Khaw;Ann Intern Med,2004

3. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus;Selvin;Ann Intern Med,2004

4. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years;Coutinho;Diabetes Care,1999

5. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?;Diabetes Care,2003

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneous Effects of Intensive Glycemic and Blood Pressure on Cardiovascular Events Among Diabetes by Living Arrangements;Journal of the American Heart Association;2024-07-02

2. Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events;Frontiers in Endocrinology;2024-02-14

3. Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study;Cardiovascular Diabetology;2023-10-27

4. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65;Scientific Reports;2023-10-12

5. Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial;Diabetologia;2023-09-16